Found: 8
Select item for more details and to access through your institution.
Targeting phosphoglycerate dehydrogenase in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-020-00196-w
- By:
- Publication type:
- Article
Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 31, doi. 10.1111/ejh.13766
- By:
- Publication type:
- Article
Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells.
- Published in:
- Molecules, 2021, v. 26, n. 24, p. 7447, doi. 10.3390/molecules26247447
- By:
- Publication type:
- Article
Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma.
- Published in:
- FASEB Journal, 2021, v. 35, n. 3, p. 1, doi. 10.1096/fj.202001920RR
- By:
- Publication type:
- Article
Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.636375
- By:
- Publication type:
- Article
TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.
- Published in:
- BMC Research Notes, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13104-022-06237-3
- By:
- Publication type:
- Article
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Will deeper characterization of the landscape of immune checkpoint molecules in acute myeloid leukemia bone marrow lead to improved therapeutic targeting?
- Published in:
- 2019
- By:
- Publication type:
- Editorial